The associations between common neuroimaging parameters of Progressive Supranuclear Palsy in magnetic resonance imaging and non-specific inflammatory factors – pilot study
Authors:
Open Access
- 8 August 2024
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 15, 1458713
Abstract
Progressive Supranuclear Palsy is an atypical parkinsonism based on tauopathic pathology. Growing interest is associated with the pathomechanism of this disease. Among theories analyzing this issue can be mentioned the one highlighting the significance of inflammation. In this study authors examined 14 patients with PSP-Richardson syndrome (PSP-RS) and 13 healthy volunteers using laboratory testing based on the analysis of interleukins 1 and 6 (IL-1 and IL-6), tau in the cerebrospinal fluid (CSF) and non-specific parameters of peripheral inflammation in the serum (IL-1, IL-6, neutrophils, lymphocytes, monocytes, platelets and the ratios based on the factors). All of the patients underwent neuroimaging using magnetic resonance imaging using 3 Tesla. The serum levels of IL-1 were positively correlated with the area of the mesencephalon, suggesting that higher levels of IL-1 are not linked with atrophic changes in this region, whereas serum levels IL-6 was positively correlated with frontal horn width and negatively correlated with superior cerebellar area. Additionally IL-6 in the serum was found to be correlated with neutrophil-to-high density lipoprotein ratio. The observations were not confirmed in the analysis of the levels of interleukins in the CSF. To the best of our knowledge this work is one of the first analyzing this issue. The outcome of the work shows that the role of interleukins associated with microglial activation may possibly differ in the context of neurodegenerative changes, moreover the role of peripheral inflammation in PSP requires further analysis.Keywords
This publication has 27 references indexed in Scilit:
- Stepwise Functional Brain Architecture Correlates with Atrophy in Progressive Supranuclear PalsyMovement Disorders, 2024
- Magnetic Resonance Imaging Measures to Track Atrophy Progression in Progressive Supranuclear Palsy in Clinical TrialsMovement Disorders, 2024
- Clinical Utility of Tectal Plate Measurements on Magnetic Resonance Imaging in Progressive Supranuclear PalsyMovement Disorders, 2024
- “Parkinson’s disease” on the way to progressive supranuclear palsy: a review on PSP-parkinsonismNeurological Sciences, 2021
- Altered oligodendroglia and astroglia in chronic traumatic encephalopathyActa Neuropathologica, 2021
- Microglial activation arises after aggregation of phosphorylated-tau in a neuron-specific P301S tauopathy mouse modelNeurobiology of Aging, 2020
- The neutrophil-to-lymphocyte ratio as a marker of peripheral inflammation in progressive supranuclear palsy: a retrospective studyNeurological Sciences, 2020
- Cathepsin S increases tau oligomer formation through limited cleavage, but only IL-6, not cathespin S serum levels correlate with disease severity in the neurodegenerative tauopathy progressive supranuclear palsyExperimental Brain Research, 2017
- Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteriaMovement Disorders, 2017
- Cytokine expression and microglial activation in progressive supranuclear palsyParkinsonism & Related Disorders, 2011